Our results show that a six-month treatment with ezetimibe+fenofibrate is well tolerated and is as effective as pravastatin in reducing LDL cholesterol, while being also able to reduce triglycerides and to increase HDL cholesterol, both instead unchanged with pravastatin monotherapy
Our results show that a six-month treatment with ezetimibe+fenofibrate is well tolerated and is as effective as pravastatin in reducing LDL cholesterol, while being also able to reduce triglycerides and…